Net Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2017

Earnings Per Share [Abstract]

Schedule of Net Loss Per Share

The following table reconciles net loss to net loss attributable to Heat Biologics, Inc.:

	For the years ended December 31,
	2017			2016
Net loss	$	(12,409,866	)	$	(12,974,799	)
Net loss - Non-controlling interest		(568,195	)		(400,847	)
Net loss attributable to Heat Biologics, Inc.	$	(11,841,671	)	$	(12,573,952	)
Weighted-average number of common shares used in net loss per share attributable to common stockholders —basic and diluted		3,845,342			1,758,621
Net loss per share attributable to Heat Biologics, Inc —basic and diluted	$	(3.08	)	$	(7.15	)

Schedule of Potentially Dilutive Securities

The following potentially dilutive securities were excluded from the calculation of diluted net loss per share due to their anti-dilutive effect:

	For the years ended December 31,
	2017		2016
Outstanding stock options		266,810		113,672
Unvested restricted stock units		21,779		5,625
Outstanding common stock warrants		310,397		310,397